Clinical Trial Update: T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing T cell responses to the Varicella Zoster Virus vaccine SLVP020 in adults with herpes zoster; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• SLVP020

Snippet

Sponsor: Stanford University | Conditions: Herpes Zoster | Phase 4 | Status: COMPLETED | Results posted: 2017-03-03